A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 5, 2011, Pages 529-536

  Schnur, Julie B ^a   Love, Bianca ^a   Scheckner, Bari L ^a   Green, Sheryl ^b   Gabriella, A ^b   Montgomery, Guy H ^a  

^a Cornell University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

breast neoplasms; patient outcome assessments; radiodermatitis; radiotherapy

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IRRADIATION; RADIATION DERMATITIS; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BRACHYTHERAPY; BREAST NEOPLASMS; FEMALE; HUMANS; RADIODERMATITIS;

EID: 80053345913     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181e84b36     Document Type: Review

References (54)

1. National Cancer Database (NCDB)/Commission on Cancer (CoC). NCDB Hospital Comparison Benchmark Reports [database online]. Chicago, IL: American College of Surgeons; 2006
2. Wengstrom Y, Haggmark C, Strander H, et al. Perceived symptoms and quality of life in women with breast cancer receiving radiation therapy. Eur J Oncol Nurs. 2000;4:78-88.
3. Knobf MT, Sun Y. A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for breast cancer. Cancer Nurs. 2005;28:210-218. (Pubitemid 40734540)
4. Berthelet E, Truong PT, Musso K, et al. Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol. 2004;27:626-631. (Pubitemid 39603279)
5. Freedman GM, Li T, Nicolaou N, et al. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys. 2009;74:689-694.
6. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
7. Harper JL, Franklin LE, Jenrette JM, et al. Skin toxicity during breast irradiation: pathophysiology and management. South Med J. 2004;97:989-993. (Pubitemid 39391830)
8. Mendelsohn FA, Divino CM, Reis ED, et al. Wound care after radiation therapy. Adv Skin Wound Care. 2002;15:216-224.
9. McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs. 2006;22:163-173. (Pubitemid 44163101)
10. Bourgeois JF, Gourgou S, Kramar A, et al. A randomized, prospective study using the LPG technique in treating radiationinduced skin fibrosis: clinical and profilometric analysis. Skin Res Technol. 2008;14:71-76.
11. Noble-Adams R. Radiation-induced reactions. 1: an examination of the phenomenon. Br J Nurs. 1999;8:1134-1140.
12. MacBride SK, Wells ME, Hornsby C, et al. A case study to evaluate a new soft silicone dressing, Mepilex Lite, for patients with radiation skin reactions. Cancer Nurs. 2008;31:E8-E14.
13. Schnur JB, Ouellette SC, DiLorenzo TA, et al. A qualitative analysis of skin toxicity among breast cancer radiotherapy patients. Psychooncology. 2011;20:260-268.
14. Kuroi K, Shimozuma K, Ohsumi S, et al. Current status of health outcome assessment of medical treatment in breast cancer. Breast Cancer. 2007;14:74-80.
15. Wells M, Macmillan M, Raab G, et al. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol. 2004;73:153-162. (Pubitemid 39470154)
16. Delaney G, Fisher R, Hook C, et al. Sucralfate cream in the management of moist desquamation during radiotherapy. Australas Radiol. 1997;41:270-275. (Pubitemid 27360215)
17. World Health Organization. Constitution of the World Health Organization. Available at: http://www.who.int/governance/eb/who-constitution-en.pdf. Accessed March 19, 2010.
18. National Cancer Policy Board, Institute of Medicine. Meeting Psychosocial Needs of Women with Breast Cancer. Washington, D.C.: National Academies Press; 2004.
19. National Cancer Policy Board, Institute of Medicine and National Research Council. Ensuring Quality Cancer Care. Washington, D.C.: The National Academies Press; 1999.
20. Lipscomb J, Gotay CC, Snyder C, eds. Outcomes Assessment in Cancer: Measures, Methods and Applications. New York: Cambridge University Press 2005.
21. Perry S, Kowalski TL, Chang CH. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes. 2007;5:24.
22. Cella D, Wagner L, Cashy J, et al. Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy. J Natl Cancer Inst Monogr. 2007;37:53-60.
23. Schmuth M, Wimmer MA, Hofer S, et al. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol. 2002;146:983-991. (Pubitemid 34779478)
24. Lepore SJ, Helgeson VS. Social constraints, intrusive thoughts, and mental health after prostate cancer. J Soc Clin Psychol. 1998;17:89-106.
25. Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). Common Terminology Criteria for Adverse Events (CTCAE): Version 4.0. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda: Maryland 2009. v4.02: September 15, 2009.
26. Noble-Adams R. Radiation-induced skin reactions. 2: Development of a measurement tool. Br J Nurs. 1999;8:1208-1211.
27. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896-1900.
28. Bennett C. An investigation into the use of a non-metallic deodorant during radiotherapy treatment: a randomised controlled trial. J Radiother Pract. 2009;8:3-9.
29. Glees JP, Mameghan-Zadeh H, Sparkes CG. Effectiveness of topical steroids in the control of radiation dermatitis: a randomised trial using 1% hydrocortisone cream and 0.05% clobetasone butyrate (Eumovate). Clin Radiol. 1979;30:397-403. (Pubitemid 9207923)
30. Graham P, Browne L, Capp A, et al. Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation. Int J Radiat Oncol Biol Phys. 2004;58:241-246. (Pubitemid 38010358)
31. Halyard MY, McCombs KE, Wong WW, et al. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004;27:389-394. (Pubitemid 39045250)
32. Heggie S, Bryant GP, Tripcony L, et al. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs. 2002;25:442-451. (Pubitemid 35424054)
33. Dische S,Warburton MF, Jones D, et al. The recording of morbidity related to radiotherapy. Radiother Oncol. 1989;16:103-108. (Pubitemid 19258948)
34. Macmillan MS, Wells M, MacBride S, et al. Randomized comparison of dry dressings versus hydrogel in management of radiation-induced moist desquamation. Int J Radiat Oncol Biol Phys. 2007;68:864-872. (Pubitemid 46818726)
35. Pommier P, Gomez F, Sunyach MP, et al. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22:1447-1453. (Pubitemid 41103627)
36. Porock D, Kristjanson L. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. Eur J Cancer Care (Engl). 1999;8:143-153.
37. Primavera G, Carrera M, Berardesca E, et al. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis. Cutan Ocul Toxicol. 2006;25:165-171. (Pubitemid 44410610)
38. Roper B, Kaisig D, Auer F, et al. Theta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care? Strahlenther Onkol. 2004;180:315-322. (Pubitemid 38667752)
39. Schlappack O. Homeopathic treatment of radiation-induced itching in breast cancer patients. A prospective observational study. Homeopathy. 2004;93:210-215. (Pubitemid 39311929)
40. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707-713. (Pubitemid 26371086)
41. Schnur JB, Montgomery GH. Hypnosis and cognitive-behavioral therapy during breast cancer radiotherapy: a case report. Am J Clin Hypn. 2008;50:209-215.
42. Szumacher E, Wighton A, Franssen E, et al. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys. 2001;51:81-86. (Pubitemid 32758865)
43. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216. (Pubitemid 24194579)
44. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9:169-180. (Pubitemid 38457276)
45. Williams MS, Burk M, Loprinzi CL, et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiationinduced skin toxicity. Int J Radiat Oncol Biol Phys. 1996; 36:345-349. (Pubitemid 26359459)
46. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26: 2085-2092.
47. Bolderston A, Lloyd NS, Wong RK, et al. The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer. 2006;14:802-817. (Pubitemid 44060993)
48. Kedge EM. A systematic review to investigate the effectiveness and acceptability of interventions for moist desquamation in radiotherapy patients. Radiography. 2009;15:247-257.
49. Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol. 2001;58:333-339. (Pubitemid 32181869)
50. Campbell IR, Illingworth MH. Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol (R Coll Radiol). 1992;4:78-82.
51. Lokkevik E, Skovlund E, Reitan JB, et al. Skin treatment with bepanthen cream versus no cream during radiotherapy-a randomized controlled trial. Acta Oncol. 1996;35:1021-1026.
52. Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol. 2009;20:17-25.
53. Kirkova J, Davis MP, Walsh D, et al. Cancer symptom assessment instruments: a systematic review. J Clin Oncol. 2006;24: 1459-1473. (Pubitemid 46622014)
54. Hjermstad MJ, Fainsinger R, Kaasa S. Assessment and classification of cancer pain. Curr Opin Support Palliat Care. 2009;3: 24-30.